FDA Inspection 1248229 — The Harvard Drug Group, LLC
The FDA completed an inspection of The Harvard Drug Group, LLC on Aug 21, 2024 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 21, 2024
- Fiscal Year
- 2024
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Indianapolis, IN (United States)